Given the present cash balance and upcoming partner payments we don’t think investors have to worry about cash anytime soon. The question will be, how fast can the company ramp sales to grow into its $1.4B valuation. We think signing up 100K US patients, not even counting foreign royalty income, would do the trick, which […]
Entries Tagged as 'ESPR'
May 24th, 2020 · Comments Off on Esperion Has A Low Bar To Climb To Warrant Its Present Valuation